Biotech · Private company · Houston, TX, US
Cellchorus Inc.
Track this companyFree. Adds Cellchorus Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Dynamic single-cell analysis instrument commercial readiness (CRP)Fiscal year 2026 · $998.9KNIH RePORTER 1SB1GM163323-01 · fetched Nov 12, 2026
- LF-TIMING: Large-scale label-free profiling of cell-cell interactionsFiscal year 2026 · $1MNIH RePORTER 5R42TR005299-03 · fetched Nov 12, 2026
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturingFiscal year 2026 · $1MNIH RePORTER 5R44TR005137-03 · fetched Nov 12, 2026
- Functional signatures of post-infusion CAR T cells for early indication of patient responseFiscal year 2025 · $399.6KNIH RePORTER 1R43CA298411-01A1 · fetched Nov 12, 2026
- Dynamic single-cell analysis instrument to evaluate immune cell functionFiscal year 2025 · $56.4KNIH RePORTER 3R44GM149106-03S1 · fetched Nov 12, 2026
- LF-TIMING: Large-scale label-free profiling of cell-cell interactionsFiscal year 2025 · $1.1MNIH RePORTER 4R42TR005299-02 · fetched Nov 12, 2026
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturingFiscal year 2025 · $984.2KNIH RePORTER 4R44TR005137-02 · fetched Nov 12, 2026
- Dynamic single-cell analysis instrument to evaluate immune cell functionFiscal year 2025 · $462.8KNIH RePORTER 5R44GM149106-03 · fetched Nov 12, 2026
- LF-TIMING: Large-scale label-free profiling of cell-cell interactionsFiscal year 2024 · $349.2KNIH RePORTER 1R42TR005299-01 · fetched Nov 12, 2026
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturingFiscal year 2024 · $350KNIH RePORTER 1R44TR005137-01 · fetched Nov 12, 2026